ENTO logo

Entero Therapeutics (ENTO) Current Assets

Annual Current Assets

$4.96 M
+$1.54 M+45.22%

December 31, 2023


Summary


Performance

ENTO Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTObalance sheetmetrics:

Quarterly Current Assets

$83.84 M
-$544.60 K-0.65%

September 1, 2024


Summary


Performance

ENTO Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTObalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

ENTO Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+45.2%+1591.7%
3 y3 years-37.0%+2275.2%
5 y5 years+3.3%+2147.9%

ENTO Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.4%+45.2%-0.7%+4586.3%
5 y5-year-47.4%+45.4%-0.7%+5137.2%
alltimeall time-47.4%+647.0%-0.7%+6058.5%

Entero Therapeutics Current Assets History

DateAnnualQuarterly
Sep 2024
-
$83.84 M(-0.6%)
Jun 2024
-
$84.39 M(+1026.7%)
Mar 2024
-
$7.49 M(+51.1%)
Dec 2023
$1.93 M(-4.9%)
$4.96 M(+24.6%)
Sep 2023
-
$3.98 M(+68.9%)
Jun 2023
-
$2.35 M(-33.3%)
Mar 2023
-
$3.53 M(+3.4%)
Dec 2022
$2.03 M(-14.3%)
-
Dec 2022
-
$3.41 M(+33.9%)
Sep 2022
-
$2.55 M(+42.5%)
Jun 2022
-
$1.79 M(-72.7%)
Mar 2022
-
$6.55 M(-30.5%)
Dec 2021
$2.37 M(-53.2%)
$9.43 M(+25.6%)
Sep 2021
-
$7.50 M(-12.9%)
Jun 2021
-
$8.62 M(-34.6%)
Mar 2021
-
$13.17 M(+67.4%)
Dec 2020
$5.05 M
$7.87 M(-31.8%)
Sep 2020
-
$11.54 M(+620.7%)
Jun 2020
-
$1.60 M(-44.7%)
DateAnnualQuarterly
Mar 2020
-
$2.90 M(-15.0%)
Dec 2019
$5.49 M(+105.8%)
$3.41 M(-8.6%)
Sep 2019
-
$3.73 M(+2.8%)
Jun 2019
-
$3.63 M(+29.4%)
Mar 2019
-
$2.80 M(-41.6%)
Dec 2018
$2.67 M(-24.3%)
$4.80 M(-15.5%)
Sep 2018
-
$5.68 M(-34.2%)
Jun 2018
-
$8.63 M(+378.1%)
Mar 2018
-
$1.81 M(-7.5%)
Dec 2017
$3.53 M(-6.9%)
$1.95 M(-38.7%)
Sep 2017
-
$3.18 M(-36.7%)
Jun 2017
-
$5.03 M(+187.4%)
Mar 2017
-
$1.75 M(-41.0%)
Dec 2016
$3.79 M(-17.9%)
$2.96 M(+117.7%)
Sep 2016
-
$1.36 M(-39.6%)
Jun 2016
-
$2.25 M(+33.5%)
Mar 2016
-
$1.69 M(-18.3%)
Dec 2015
$4.62 M(-21.9%)
$2.07 M
Dec 2014
$5.91 M
-

FAQ

  • What is Entero Therapeutics annual total current assets?
  • What is the all time high annual current assets for Entero Therapeutics?
  • What is Entero Therapeutics annual current assets year-on-year change?
  • What is Entero Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Entero Therapeutics?
  • What is Entero Therapeutics quarterly current assets year-on-year change?

What is Entero Therapeutics annual total current assets?

The current annual current assets of ENTO is $4.96 M

What is the all time high annual current assets for Entero Therapeutics?

Entero Therapeutics all-time high annual total current assets is $9.43 M

What is Entero Therapeutics annual current assets year-on-year change?

Over the past year, ENTO annual total current assets has changed by +$1.54 M (+45.22%)

What is Entero Therapeutics quarterly total current assets?

The current quarterly current assets of ENTO is $83.84 M

What is the all time high quarterly current assets for Entero Therapeutics?

Entero Therapeutics all-time high quarterly total current assets is $84.39 M

What is Entero Therapeutics quarterly current assets year-on-year change?

Over the past year, ENTO quarterly total current assets has changed by +$78.89 M (+1591.66%)